电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

AMOTL2 抗体

(Angiomotin Like 2 (AMOTL2))
Angiomotin is a protein that binds angiostatin, a circulating inhibitor of the formation of new blood vessels (angiogenesis). Angiomotin mediates angiostatin inhibition of endothelial cell migration and tube formation in vitro. The protein encoded by this gene is related to angiomotin and is a member of the motins protein family. [provided by RefSeq, Jul 2008].

22 results

AMOTL2 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
产品编号 ABIN2200112
 
AMOTL2 适用: 人 ELISA, WB 宿主: 兔 Polyclonal APC
产品编号 ABIN2200114
 
  • 类型 Primary
    • Primary
  • 应用范围
    • Western Blotting (WB)
    • ELISA
    • Immunohistochemistry (IHC)
    • Immunofluorescence (IF)
    • Immunocytochemistry (ICC)
  • 适用
    • Human
    • Mouse
    • Rat
  • 论文引用
  • 图像
  • Carrier free only
  • 抗体来源
    • Rabbit
  • 克隆形成能力
    • Polyclonal
  • 克隆
    • RB22761
  • 抗原表位
    • AA 718-737
    • AA 126-152
    • Center
    • Internal Region
    • AA 132-161
    • AA 401-480
    • AA 540-653
    • AA 6-235
    • AA 638-837
  • 标记
    • 非结合性
    • APC
    • Alexa Fluor 488
    • Alexa Fluor 555
    • Alexa Fluor 594
    • Alexa Fluor 647
    • Alexa Fluor 680
    • Alexa Fluor 750
    • Biotin
    • FITC
    • HRP
  • 抗体亚型
    • IgG
    • Ig Fraction
  • Format
    • Liquid
    • Lyophilized
  • Supplier
    • antibodies-online
    • Signalway
    • USBio
    • Abbexa
    • Abcepta
    • Biomatik
    • Boster Bio
    • Enogene Biotech
    • ProSci

Latest Publications for our AMOTL2 抗体

Proszynski, Sanes: "Amotl2 interacts with LL5?, localizes to podosomes and regulates postsynaptic differentiation in muscle." in: Journal of cell science, Vol. 126, Issue Pt 10, pp. 2225-35, (2013) (PubMed).

Aliases for AMOTL2 抗体

angiomotin like 2 (AMOTL2) 抗体
angiomotin-like 2 (Amotl2) 抗体
angiomotin like 2 (Amotl2) 抗体
angiomotin like 2 (amotl2) 抗体
angiomotin like 2b (amotl2b) 抗体
AW549739 抗体
C79691 抗体
LCCP 抗体
Lccp 抗体
MASCOT 抗体
mKIAA0989 抗体
zgc:154007 抗体
You are here:
Chat with us!